- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 7.39M sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $34.6M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $33.48M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $29.4M |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $25.79M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $53.23M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $53.63M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $86.39M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $98.59M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $5.18M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $4.73M |
| Current Assets | Q1 2025 · Mar 29, 2025 | $85.98M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $97.04M |
| Total Assets | Q1 2025 · Dec 28, 2024 | $132.08M |
| Total Assets | Q1 2025 · Mar 30, 2024 | $120.48M |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 8.17M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $0 |
| Capex | Q1 2025 · Mar 30, 2024 | $669K |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $6.43M |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $0.48 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $0.50 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $14.2M |
| Net Income | Q1 2025 · Mar 30, 2024 | $3.95M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $5.84M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $20.37M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $51.57M |